| Product NDC: | 76346-073 |
| Proprietary Name: | Korlym |
| Non Proprietary Name: | Mifepristone |
| Active Ingredient(s): | 300 mg/1 & nbsp; Mifepristone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 76346-073 |
| Labeler Name: | Corcept Therapeutics Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202107 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120217 |
| Package NDC: | 76346-073-01 |
| Package Description: | 28 TABLET in 1 BOTTLE (76346-073-01) |
| NDC Code | 76346-073-01 |
| Proprietary Name | Korlym |
| Package Description | 28 TABLET in 1 BOTTLE (76346-073-01) |
| Product NDC | 76346-073 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mifepristone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120217 |
| Marketing Category Name | NDA |
| Labeler Name | Corcept Therapeutics Inc |
| Substance Name | MIFEPRISTONE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Progestational Hormone Receptor Antagonists [MoA],Progestin Antagonist [EPC] |